AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Get Free Report)’s stock price dropped 2.6% on Wednesday . The stock traded as low as $20.12 and last traded at $20.63. Approximately 50,314 shares changed hands during mid-day trading, an increase of 70% from the average daily volume of 29,556 shares. The stock had previously closed at $21.17.
AdvisorShares Psychedelics ETF Stock Down 5.5%
The firm has a fifty day simple moving average of $19.39 and a two-hundred day simple moving average of $18.14.
Institutional Trading of AdvisorShares Psychedelics ETF
A hedge fund recently bought a new stake in AdvisorShares Psychedelics ETF stock. CIBC Bancorp USA Inc. purchased a new stake in AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 25,019 shares of the company’s stock, valued at approximately $475,000. CIBC Bancorp USA Inc. owned approximately 2.50% of AdvisorShares Psychedelics ETF as of its most recent SEC filing.
About AdvisorShares Psychedelics ETF
The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.
Featured Articles
- Five stocks we like better than AdvisorShares Psychedelics ETF
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for AdvisorShares Psychedelics ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvisorShares Psychedelics ETF and related companies with MarketBeat.com's FREE daily email newsletter.
